Dr. Janet Englund is professor of pediatrics at the University of Washington School of Medicine and Seattle Children’s Hospital. She studies new viral vaccines and novel agents for the treatment of respiratory viruses including influenza and respiratory syncytial virus (RSV). Dr. Englund has a longstanding interest in maternal immunization and is actively involved in studies of the prevention, treatment, and outcome of respiratory viral diseases in transplant recipients of all ages. Dr. Englund’s research group at Seattle Children’s Hospital is part of the New Vaccine Surveillance Network of the Centers for Disease Control and Prevention (CDC) (2010-2021), participating in respiratory and gastrointestinal viral surveillance. This group assesses vaccine effectiveness of rotavirus and influenza virus vaccines in population-based studies of healthy and sick children and is involved in epidemiological studies of other viruses. Her group is also studying new methods to diagnose and characterize viral respiratory diseases.
Dr. Englund has been active in national and international organizations including the American Academy of Pediatrics (AAP), the CDC Advisory Committee on Immunization Practices (ACIP), the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRPBAC), and the Maternal Immunization Safety Group at the World Health Organization (WHO). She is past-president of the Pediatric Infectious Disease Society, and a past member of the WHO Influenza working group, and the Board of Directors of the Infectious Disease Society of America.
Janet A. Englund, MD Presentations
June 18, 2020 at 4:00 PM - 4:15 PM
New vaccines are being developed in special populations that propose novel challenges such as immune suppression, pregnancy, and age. This session will explore approaches to solicit immune responses to vaccination in certain target populations.